In a recent study on a cohort of patients with NSCLC achieving long-term benefit from PD-1/PD-L1 blockade, patients with positive detection of ctDNA at late surveillance time points were more likely to develop disease progression. The gene discussed is CD274; the disease is non-small cell lung carcinoma.